{"schema_version":"secwatch.filing_event.v1","accession":"0001698530-25-000017","form_type":"8-K","ticker":"XCUR","cik":"0001698530","company_name":"EXICURE, INC.","filed_at":"2025-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.485724+00:00","generated_at":"2026-05-24T13:59:52.534752+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Exicure reports FY2024 net loss of $9.7M, cash $12.5M, going concern warning","bullets":["Cash and cash equivalents $12.5M as of Dec 31, 2024, up from $0.8M year-end 2023; management warns liquidity may not last 12 months.","Net loss of $9.7M for FY2024, compared to net loss of $16.9M in FY2023; decrease driven by lower G&A and asset sale income.","R&D expenses $0 for FY2024 (from $1.4M) reflecting cessation of all R&D activities; G&A expenses $5.4M (from $11.7M).","Company continues exploring strategic alternatives, including transactions with potential partners; substantial doubt about going concern.","Sold clinical product samples and certain assets in 2024 to a private biopharma; no further operational details."],"urls":{"canonical":"https://secwatch.observer/filing/0001698530-25-000017","json":"https://secwatch.observer/filing/0001698530-25-000017.json","markdown":"https://secwatch.observer/filing/0001698530-25-000017.md","text":"https://secwatch.observer/filing/0001698530-25-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1698530/000169853025000017/0001698530-25-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1698530/000169853025000017/xcur-20250318.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T13:59:52.534752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}